CH de Pau — Pau

Public research footprint of CH de Pau, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Coronary Artery Disease · Arthritis, Rheumatoid · Anaplastic Large Cell Lymphoma Associated With Breast Implants…

Recently updated registry entries

NCT04196868 — Methotrexate and Metformin in Rheumatoid Arthritis Patients (Completed)
NCT05098704 — Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk (Recruiting)
NCT03296202 — Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CH de Pau?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.